Terminated EARLY_PHASE1 INTERVENTIONAL 2-arm NCT06312657

Behavioral Effects of Drugs Inpatient 44 Neurobehavioral Mechanisms of Opioid Choice (BED(In)(44))

Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice

Sponsor: Joshua A. Lile, Ph.D.

Updated 7 times since 2024 Last updated: Nov 30, 2025 Started: Mar 1, 2023 Primary completion: Mar 28, 2025 Completion: Mar 28, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding ended

Other Opioid Use Disorder trials with similar outcome

Browse all Opioid Use Disorder trials

This EARLY_PHASE1 trial investigates Opioid Use Disorder and is currently terminated or withdrawn. Joshua A. Lile, Ph.D. leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Terminated EARLY_PHASE1

Status: Recruiting → Terminated
Aug 2025 — Jan 2026 [monthly]

Recruiting EARLY_PHASE1
Sep 2024 — Aug 2025 [monthly]

Recruiting EARLY_PHASE1
Aug 2024 — Sep 2024 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

▶ Show 2 earlier versions

May 2024 — Jul 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Apr 2024 — May 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Joshua A. Lile, Ph.D.
National Institute on Drug Abuse (NIDA)

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States